Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirotaka Watada

Showing results (81-90 of 515) with videos related to

Pageof 52
Sort By:
Internal Medicine (Tokyo, Japan)|November 5, 2010
Fulminant emphysematous pyelonephritis (EPN) in a diabetic patient suspected of having multiple tumorsJunko Sato, Hajime M Koyano, Ruri Sasaki, et al.
Diabetes/Metabolism Research and Reviews|May 9, 2016
Comparison of insulin lispro mix 25 with insulin lispro mix 50 as an insulin starter in Asian patients with type 2 diabetes: a phase 4, open-label, randomized trial (CLASSIFY study)Hirotaka Watada, Qing Su, Peng Fei Li, et al.
Advances in Therapy|March 1, 2018
Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week StudyYuichiro Yamada, Yasuo Terauchi, Hirotaka Watada, et al.
Expert Opinion on Drug Safety|June 20, 2020
Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trialsHirotaka Watada, Toshimasa Yamauchi, Fumiko Yamamoto, et al.
Endocrine Journal|September 6, 2007
Glucose homeostasis in a diabetic patient during liver transplantation: a case reportMasayuki Arakawa, Takahisa Hirose, Tomoya Mita, et al.
Diabetes, Obesity & Metabolism|August 5, 2022
Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on JapanTakashi Kadowaki, Hiroshi Maegawa, Hirotaka Watada, et al.
Diabetes Research and Clinical Practice|May 20, 2008
Effects of changes in basal/total daily insulin ratio in type 2 diabetes patients on intensive insulin therapy including insulin glargine (JUN-LAN Study 6)Motoyuki Tamaki, Tomoaki Shimizu, Akio Kanazawa, et al.
Endocrine Journal|January 18, 2006
Characteristics of Japanese subjects who progress from normal to impaired glucose tolerance. Longitudinal study excluding changes in body weightYasuhiro Igarashi, Tomoya Mita, Ryuzo Mizuno, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 21, 2017
Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan-A ProtocolNaoto Katakami, Tomoya Mita, Mitsuyoshi Takahara, et al.
Biochemical and Biophysical Research Communications|October 20, 2009
Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contentsMasayuki Arakawa, Chie Ebato, Tomoya Mita, et al.
Pageof 52

Showing results (81-90 of 515) with videos related to

Sort By:
Pageof 52
Internal Medicine (Tokyo, Japan)|November 5, 2010
Fulminant emphysematous pyelonephritis (EPN) in a diabetic patient suspected of having multiple tumorsJunko Sato, Hajime M Koyano, Ruri Sasaki, et al.
Diabetes/Metabolism Research and Reviews|May 9, 2016
Comparison of insulin lispro mix 25 with insulin lispro mix 50 as an insulin starter in Asian patients with type 2 diabetes: a phase 4, open-label, randomized trial (CLASSIFY study)Hirotaka Watada, Qing Su, Peng Fei Li, et al.
Advances in Therapy|March 1, 2018
Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week StudyYuichiro Yamada, Yasuo Terauchi, Hirotaka Watada, et al.
Expert Opinion on Drug Safety|June 20, 2020
Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trialsHirotaka Watada, Toshimasa Yamauchi, Fumiko Yamamoto, et al.
Endocrine Journal|September 6, 2007
Glucose homeostasis in a diabetic patient during liver transplantation: a case reportMasayuki Arakawa, Takahisa Hirose, Tomoya Mita, et al.
Diabetes, Obesity & Metabolism|August 5, 2022
Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on JapanTakashi Kadowaki, Hiroshi Maegawa, Hirotaka Watada, et al.
Diabetes Research and Clinical Practice|May 20, 2008
Effects of changes in basal/total daily insulin ratio in type 2 diabetes patients on intensive insulin therapy including insulin glargine (JUN-LAN Study 6)Motoyuki Tamaki, Tomoaki Shimizu, Akio Kanazawa, et al.
Endocrine Journal|January 18, 2006
Characteristics of Japanese subjects who progress from normal to impaired glucose tolerance. Longitudinal study excluding changes in body weightYasuhiro Igarashi, Tomoya Mita, Ryuzo Mizuno, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 21, 2017
Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan-A ProtocolNaoto Katakami, Tomoya Mita, Mitsuyoshi Takahara, et al.
Biochemical and Biophysical Research Communications|October 20, 2009
Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contentsMasayuki Arakawa, Chie Ebato, Tomoya Mita, et al.
Pageof 52